Molecular Therapy - Nucleic Acids

Slides:



Advertisements
Similar presentations
Volume 150, Issue 1, Pages (July 2016)
Advertisements

DNA Methylation Regulates Gene Expression in Intracranial Aneurysms
Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma  Kuang-Tzu Huang, I-Ying Kuo, Ming-Chao.
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Volume 2, Issue 2, Pages (February 2016)
Volume 80, Issue 4, Pages (August 2011)
Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis  Junle Zhu, Jingliang Ye, Lei Zhang, Lili Xia,
Volume 21, Issue 11, Pages (December 2017)
Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer  Fangfang Fu, Weiqin Jiang, Linfu Zhou, Zhi Chen 
Kenneth G. Geles, Wenyan Zhong, Siobhan K
Molecular Therapy - Nucleic Acids
Volume 21, Issue 13, Pages (December 2017)
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion  Weibing Qin, M.D., Ph.D., Yunge Tang, M.D., Ning.
Volume 18, Issue 12, Pages (March 2017)
Altered microRNA expression in stenoses of native arteriovenous fistulas in hemodialysis patients  Lei Lv, MD, Weibin Huang, MD, Jiwei Zhang, MD, Yaxue.
Volume 11, Issue 2, Pages (August 2012)
Unmasking Transcriptional Heterogeneity in Senescent Cells
Transcriptome-wide Investigation of mRNA/circRNA in miR-184 and Its r
Revealing Global Regulatory Perturbations across Human Cancers
Volume 35, Issue 2, Pages (July 2009)
Volume 23, Issue 4, Pages (April 2018)
Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer  Meng Zhou, Long Hu, Zicheng.
Volume 33, Issue 4, Pages e6 (April 2018)
Volume 25, Issue 3, Pages (March 2017)
Andrew D. Bosson, Jesse R. Zamudio, Phillip A. Sharp  Molecular Cell 
TED-Seq Identifies the Dynamics of Poly(A) Length during ER Stress
Volume 48, Issue 5, Pages (December 2012)
Volume 12, Issue 6, Pages (December 2003)
Volume 10, Issue 6, Pages (June 2018)
A meta-analysis of expression signatures in glomerular disease
Volume 23, Issue 8, Pages (August 2015)
Volume 21, Issue 11, Pages (December 2017)
Volume 23, Issue 7, Pages (May 2018)
Volume 24, Issue 12, Pages e5 (September 2018)
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice  J.P. Schanstra, M. Bachvarova, E. Neau,
Molecular Therapy - Nucleic Acids
Revealing Global Regulatory Perturbations across Human Cancers
Volume 10, Issue 3, Pages (March 2018)
Volume 9, Issue 9, Pages (September 2016)
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Volume 9, Issue 5, Pages (November 2017)
Lu Zheng, Nan You, Xiaobing Huang, Huiying Gu, Ke Wu, Na Mi, Jing Li 
Evolution of Alu Elements toward Enhancers
Volume 10, Issue 10, Pages (October 2017)
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Volume 4, Issue 3, Pages e3 (March 2017)
R.H. Brophy, B. Zhang, L. Cai, R.W. Wright, L.J. Sandell, M.F. Rai 
Molecular Therapy - Nucleic Acids
Volume 42, Issue 6, Pages (June 2011)
Genomic Profiling of Human Leishmania braziliensis Lesions Identifies Transcriptional Modules Associated with Cutaneous Immunopathology  Fernanda O. Novais,
Volume 1, Issue 1, Pages (July 2015)
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Volume 15, Issue 12, Pages (June 2016)
Volume 8, Issue 6, Pages (September 2014)
MiR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1  Qi Song, Quanbo Ji, Jingbo Xiao, Fang Li, Lingxiong Wang, Yin.
Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR p/PTEN/Akt/mTOR Pathway  Xiao-yu Li, Shan-shan Wang, Zhe Han,
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2  Cheng-Cao Sun, Ling Zhang, Guang.
Molecular Therapy - Nucleic Acids
Volume 2, Issue 3, Pages (March 2016)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Circular RNA Transcriptomic Analysis of Primary Human Brain Microvascular Endothelial Cells Infected with Meningitic Escherichia coli  Ruicheng Yang,
Volume 12, Issue 12, Pages (September 2015)
The Different Roles of miRNA-92a-2-5p and let-7b-5p in Mitochondrial Translation in db/db Mice  Huaping Li, Beibei Dai, Jiahui Fan, Chen Chen, Xiang Nie,
Volume 25, Issue 5, Pages e4 (May 2017)
Volume 27, Issue 7, Pages e4 (May 2019)
DNA Damage-Induced Transcription of Transposable Elements and Long Non-coding RNAs in Arabidopsis Is Rare and ATM-Dependent  Zhenxing Wang, Rainer Schwacke,
Presentation transcript:

Molecular Therapy - Nucleic Acids circHLA-C Plays an Important Role in Lupus Nephritis by Sponging miR-150  Junjun Luan, Congcong Jiao, Weiwei Kong, Jingqi Fu, Wei Qu, Ying Chen, Xinwang Zhu, Yu Zeng, Guangying Guo, Huimeng Qi, Li Yao, Jingbo Pi, Lining Wang, Hua Zhou  Molecular Therapy - Nucleic Acids  Volume 10, Pages 245-253 (March 2018) DOI: 10.1016/j.omtn.2017.12.006 Copyright © 2017 The Author(s) Terms and Conditions

Figure 1 The Profiling and Characteristics of circRNAs in Renal Biopsies from Patients with Lupus Nephritis and Normal Kidney Tissues (A) Clustered heatmap with each column representing a kidney tissue and each row representing a circular RNA identified by circRNA sequencing. The red indicates upregulated circRNAs, and the green indicates downregulated circRNAs. The seven circRNAs were validated by real-time qPCR (arrows). (B) Volcano plots showed differential expression of circRNAs between lupus nephritis (LN) and normal control kidneys (NC). Vertical line expressed as 2-fold (log2 scaled) up or down changes; the horizontal line represented a p value of 0.05 (−log10 scaled). Red spots indicated the differentially expressed circRNAs with statistical significance. (C) 171 circRNAs showed significant differential expression with over 2-fold change (p < 0.05) in LN group compared with NC group. 142 circRNAs were significantly upregulated (red), and 29 circRNAs were significantly downregulated (green). 39 novel circRNAs were identified (light red or green). (D) The distribution of the differentially expressed circRNAs based on the length of nuclear acids. (E) The distribution of differentially expressed circRNAs based on the location on human chromosomes. (F) The counts of differentially expressed circRNAs based on their categories of circle components. Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions

Figure 2 The Interaction Network between circRNAs and miRs A magnified network showed the top 20 upregulated circRNAs (red) and downregulated circRNAs (green) based on the ranking of fold change, statistical significance, and the involvement of LN disease activity. The top five miRs regulated by each circRNA were expressed (yellow). Seven circRNAs were validated by real-time qPCR (arrows). Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions

Figure 3 Predicted Functions of the Overexpressed circRNAs in Lupus Nephritis The top 10 predicted functions of the host gene regulated by 142 overexpressed circRNAs in renal biopsies from patients with lupus nephritis (LN) were obtained with gene oncology (GO) analysis. They were categorized based on (A) biological processes, (B) cellular components, and (C) molecular functions. The fold enrichment expressed that the regulated extent of the predicted functions by the overexpressed circRNAs in LN patients compared with normal control (NC). The arrows indicate the well-known functions involved in the pathogenesis of LN. Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions

Figure 4 HIF-1 and Neurotrophin Signal Pathways Regulated by the Overexpressed circRNAs in Lupus Nephritis Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed 23 signal pathways relate to the 142 differentially upregulated circRNAs in patients with lupus nephritis. (A) Hypoxia-inducible factor-1 (HIF-1) and (B) neurotrophin signal pathways were 2/23 pathways obtained from KEGG analysis. Both pathways were associated with activation of NF-κB, which is an important factor in the pathogenesis of lupus nephritis. Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions

Figure 5 Seven Overexpressed circRNAs in Lupus Nephritis Compared with Normal Control (A) Seven circRNAs showed same upregulation and statistical significance on real-time qPCR validation as on circRNA sequencing. The upregulated magnitudes of the seven circRNAs were expressed as a fold change of lupus nephritis (LN) to normal control (NC). (B) The relative levels of the seven circRNAs by real-time qPCR analysis in the kidneys from LN compared with NC. The levels of circRNAs from RNA sequencing were expressed as fold-change ratio of LN to NC (log2 transformed) for each circRNA. The renal levels of circRNA from real-time qPCR were expressed as a ratio of average 2−ΔΔCt of each circRNA form LN to NC. Data are expressed as means ± SD (*p < 0.05). Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions

Figure 6 The Correlation between Renal circHLA-C and Clinical Parameters in Lupus Nephritis (A) circHLA-C positively correlated with total proteinuria excretion per day. (B) A tendency of positive correlation between circHLA-C and serum creatinine. circHLA-C positively correlated with the severity of active kidney tissue damage, including (C) percentage of crescentic glomeruli and (D) score of renal activity index (AI score). Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions

Figure 7 The Interaction between Renal circHLA-C and miR-150 in Lupus Nephritis (A) The relative expression levels of renal circHLA-C and miR-150 between normal control (NC) and lupus nephritis (LN) by real-time qPCR. Data are expressed as means ± SD. (B) A tendency of negative correlation between renal miR-150 and renal circHLA-C. (C) The interaction between circHLA-C and miR-150 was predicted by TargetScan and miRanda. The “2D Structure” column shows the binding sequence of circHLA-C and miR-150 as a perfect match seed type (7-mer-m8). The “Local AU” column displays 30 nucleotides in the upstream and downstream of the seed sequence. The “Position” column indicates the probable position of miR-150 response element on the linear presentation of circHLA-C. (D) Schematic cartoon of circHLA-C in pathogenesis of LN by sponging miR-150 and other miRs. The histology image was from the renal biopsy report from patient #4 listed in Table S1 (arrow indicated a cellular crescent). Molecular Therapy - Nucleic Acids 2018 10, 245-253DOI: (10.1016/j.omtn.2017.12.006) Copyright © 2017 The Author(s) Terms and Conditions